 |
Human plasma derived conagulation protein-Factor XI |
|---|---|
| Trade Name | |
| Orphan Indication | For the treatment of congenital Factor XI deficiency |
| USA Market Approval | USA |
| USA Designation Date | 2014-04-30 00:00:00 |
| Sponsor | Cambryn Biologics;600Tallevast Rd, Unit 201;Sarasota, Florida, 34243 |
